Logo image of CROS.PA

CROSSWOOD (CROS.PA) Stock Fundamental Analysis

EPA:CROS - Euronext Paris - Matif - FR0000050395 - Common Stock - Currency: EUR

10.8  0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CROS. CROS was compared to 74 industry peers in the Real Estate Management & Development industry. CROS has an excellent financial health rating, but there are some minor concerns on its profitability. CROS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CROS had positive earnings in the past year.
CROS had a positive operating cash flow in the past year.
Of the past 5 years CROS 4 years were profitable.
CROS had a positive operating cash flow in 4 of the past 5 years.
CROS.PA Yearly Net Income VS EBIT VS OCF VS FCFCROS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.39%, CROS belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
With an excellent Return On Equity value of 6.53%, CROS belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
CROS has a Return On Invested Capital of 0.22%. This is comparable to the rest of the industry: CROS outperforms 42.86% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CROS is below the industry average of 3.47%.
Industry RankSector Rank
ROA 5.39%
ROE 6.53%
ROIC 0.22%
ROA(3y)3.13%
ROA(5y)5.13%
ROE(3y)3.87%
ROE(5y)6.65%
ROIC(3y)0.42%
ROIC(5y)0.55%
CROS.PA Yearly ROA, ROE, ROICCROS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8 10

1.3 Margins

CROS has a better Profit Margin (615.20%) than 100.00% of its industry peers.
CROS's Profit Margin has improved in the last couple of years.
CROS's Operating Margin of 29.62% is fine compared to the rest of the industry. CROS outperforms 62.86% of its industry peers.
CROS's Operating Margin has declined in the last couple of years.
CROS has a Gross Margin of 65.77%. This is in the better half of the industry: CROS outperforms 61.43% of its industry peers.
CROS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 29.62%
PM (TTM) 615.2%
GM 65.77%
OM growth 3Y-15.69%
OM growth 5Y-19.63%
PM growth 3Y0.74%
PM growth 5Y7.35%
GM growth 3Y-2.67%
GM growth 5Y-2.18%
CROS.PA Yearly Profit, Operating, Gross MarginsCROS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CROS is destroying value.
The number of shares outstanding for CROS remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CROS has about the same amount of shares outstanding.
CROS has a better debt/assets ratio than last year.
CROS.PA Yearly Shares OutstandingCROS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CROS.PA Yearly Total Debt VS Total AssetsCROS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 4.95 indicates that CROS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.95, CROS belongs to the top of the industry, outperforming 95.71% of the companies in the same industry.
CROS has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
CROS has a Debt to FCF ratio of 0.07. This is amongst the best in the industry. CROS outperforms 100.00% of its industry peers.
CROS has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
CROS has a better Debt to Equity ratio (0.00) than 92.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Altman-Z 4.95
ROIC/WACC0.03
WACC7.81%
CROS.PA Yearly LT Debt VS Equity VS FCFCROS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

CROS has a Current Ratio of 3.20. This indicates that CROS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CROS (3.20) is better than 78.57% of its industry peers.
CROS has a Quick Ratio of 3.20. This indicates that CROS is financially healthy and has no problem in meeting its short term obligations.
CROS's Quick ratio of 3.20 is amongst the best of the industry. CROS outperforms 81.43% of its industry peers.
Industry RankSector Rank
Current Ratio 3.2
Quick Ratio 3.2
CROS.PA Yearly Current Assets VS Current LiabilitesCROS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

1

3. Growth

3.1 Past

CROS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 405.11%, which is quite impressive.
CROS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.78% yearly.
CROS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.55%.
CROS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.37% yearly.
EPS 1Y (TTM)405.11%
EPS 3Y-11.3%
EPS 5Y-3.78%
EPS Q2Q%607.53%
Revenue 1Y (TTM)-11.55%
Revenue growth 3Y-11.95%
Revenue growth 5Y-10.37%
Sales Q2Q%-26.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CROS.PA Yearly Revenue VS EstimatesCROS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 21.18, the valuation of CROS can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CROS indicates a somewhat cheap valuation: CROS is cheaper than 67.14% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CROS to the average of the S&P500 Index (27.30), we can say CROS is valued slightly cheaper.
Industry RankSector Rank
PE 21.18
Fwd PE N/A
CROS.PA Price Earnings VS Forward Price EarningsCROS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CROS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 74.21
EV/EBITDA N/A
CROS.PA Per share dataCROS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

CROS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CROS!.
Industry RankSector Rank
Dividend Yield N/A

CROSSWOOD

EPA:CROS (7/8/2025, 7:00:00 PM)

10.8

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners63.64%
Inst Owner ChangeN/A
Ins Owners95.04%
Ins Owner ChangeN/A
Market Cap114.80M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.1
Dividend Growth(5Y)156.54%
DP19.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 21.18
Fwd PE N/A
P/S 129.28
P/FCF 74.21
P/OCF 56.39
P/B 1.37
P/tB 1.37
EV/EBITDA N/A
EPS(TTM)0.51
EY4.72%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.15
FCFY1.35%
OCF(TTM)0.19
OCFY1.77%
SpS0.08
BVpS7.87
TBVpS7.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.39%
ROE 6.53%
ROCE 0.26%
ROIC 0.22%
ROICexc 0.23%
ROICexgc 0.23%
OM 29.62%
PM (TTM) 615.2%
GM 65.77%
FCFM 174.21%
ROA(3y)3.13%
ROA(5y)5.13%
ROE(3y)3.87%
ROE(5y)6.65%
ROIC(3y)0.42%
ROIC(5y)0.55%
ROICexc(3y)0.43%
ROICexc(5y)0.56%
ROICexgc(3y)0.43%
ROICexgc(5y)0.56%
ROCE(3y)0.52%
ROCE(5y)0.67%
ROICexcg growth 3Y-25.56%
ROICexcg growth 5Y-29.72%
ROICexc growth 3Y-25.56%
ROICexc growth 5Y-29.71%
OM growth 3Y-15.69%
OM growth 5Y-19.63%
PM growth 3Y0.74%
PM growth 5Y7.35%
GM growth 3Y-2.67%
GM growth 5Y-2.18%
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 55.07%
Interest Coverage 3.06
Cash Conversion N/A
Profit Quality 28.32%
Current Ratio 3.2
Quick Ratio 3.2
Altman-Z 4.95
F-Score5
WACC7.81%
ROIC/WACC0.03
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)39.93%
Cap/Sales(5y)36.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)405.11%
EPS 3Y-11.3%
EPS 5Y-3.78%
EPS Q2Q%607.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.55%
Revenue growth 3Y-11.95%
Revenue growth 5Y-10.37%
Sales Q2Q%-26.68%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-61.21%
EBIT growth 3Y-25.77%
EBIT growth 5Y-27.97%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y723.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y475.14%
OCF growth 3Y52.86%
OCF growth 5YN/A